Cheshire, UK--(Marketwire - July 22, 2008) - London, UK; Brentwood, TN, US; 22 July 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, today provides
its Interim Management Statement for the period 31 March to 21
July 2008. This statement summarises comments to be made today by
Stuart Wallis, Chairman of Protherics' at the Annual General Meeting at
midday today.
